Philips CPAP Cancer Lawsuit News

Phillips CPAP Malfunctions And Using An Ozone Cleaning Solution May Go Hand In Hand

Lawsuits accuse each other of causing the sleep apnea devices foam to dissolve into a toxic stew

Sunday, July 10, 2022 - Phillips Respironics has attempted to make consumers believe that they were as surprised as anyone that their CPAP machines' sound abatement foam was prone to degrading into toxic particles, chemicals, and gasses that would pass into the device's airway and be inhaled directly into the user's lungs. The fact in the matter, however, could be that the company knew five or more years ago that the noise cancellation foam may be defective and causing health problems because the company received, and ignored numerous consumer complaints. The US Food and Drug Administration (FDA) accuses the company of knowing about the potential problem before 2015 when Phillips contacted PolyTech, the manufacturer of the foam for guidance. According to a report on TopClassActions.com, "the U.S. Food and Drug Administration found Philips was aware of consumer complaints regarding its devices and that it had reached out to its foam supplier, PolyTech, about its durability in 2015." TCA writes that Phillips also received more than 20,000 complaints on their CPAP machines that have recalled only last year according to the FDA report. Phillips is under investigation by the US Department of Justice (DOJ) for failing to respond to the FDA's Phillips CPAP recall order in a timely manner.

The FDA had ordered Phillips to immediately notify all of its CPAP, BiPAP, and other respiratory machines of the recall and provide instructions to stop using them and on how to get a replacement machine immediately. Philips was ordered by the FDA to alert consumers not to use Ozone cleaning devices on their breathing devices as they are not FDA approved and it is suspected that they may be the cause of the sound abatement foam degrading. The FDA called Phillips' response to the FDA recall order inadequate as many of the Phillips CPAP users are still, to this day, unaware that there is a recall and continue to use the machine and the unapproved cleaning solution. Hundreds of lawsuits have been filed against SoClean Cleaning Solutions alleging that the device itself is unsafe and is the cause of their Phillips CPAP cancer and other respiratory illness. The head of Phillips has told reporters that he suspects the SoClean Ozone cleaning solution as being the cause of the sound abatement foam degrading and warns users to stay clear of the product. Reuters reported that SoClean filed a $200 million lawsuit against Phillips in response to the disparaging accusations that their CPAP cleaning in the product caused the sound abatement foam to deteriorate. SoClean attorneys told Reuters, "Philips is "pointing the finger at SoClean's ozone cleaners to divert attention away from Philips' poor choice of materials and obvious design flaws" in the continuous positive airway pressure (CPAP) devices it recalled." The $200 million is, according to the company, a reflection of the loss in sales due to the damage that Phillip's accusations have done to their brand. It could also be due to consumers stopping using the device when they stopped using their recalled CPAP machine.

More Recent Philips CPAP Cancer Lawsuit News:

Lawyers for CPAP Cancer Lawsuits

We will represent all persons in involved in a BiPAP or CPAP cancer lawsuit on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. Anyone who developed cancer or another serious side effect as a result of using a Philips CPAP sleep apnea machine or ventilator in --or is a family member of such a person--is eligible to receive a free, no-obligation case review from our attorneys. Simply contact our firm through the online contact form or the chat feature and one of our Philips BiPAP cancer lawyers serving will contact you promptly to discuss your case.



Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.